Your browser doesn't support javascript.
loading
The Potential of Neuraminidase as an Antigen for Nasal Vaccines To Increase Cross-Protection against Influenza Viruses.
Kawai, Atsushi; Yamamoto, Yasuyuki; Nogimori, Takuto; Takeshita, Kohei; Yamamoto, Takuya; Yoshioka, Yasuo.
Afiliação
  • Kawai A; Laboratory of Nano-design for Innovative Drug Development, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.
  • Yamamoto Y; Vaccine Creation Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, Japan.
  • Nogimori T; Vaccine Creation Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
  • Takeshita K; BIKEN Center for Innovative Vaccine Research and Development, The Research Foundation for Microbial Diseases of Osaka University, Suita, Osaka, Japan.
  • Yamamoto T; Laboratory of Immunosenescence, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan.
  • Yoshioka Y; RIKEN SPring-8 Center, Sayo, Hyogo, Japan.
J Virol ; 95(20): e0118021, 2021 09 27.
Article em En | MEDLINE | ID: mdl-34379511

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Orthomyxoviridae / Vacinas contra Influenza / Neuraminidase Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Orthomyxoviridae / Vacinas contra Influenza / Neuraminidase Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article